Cardinal Health said March 12 it is selling its Cordis medical device business to private equity firm Hellman & Friedman for roughly $1 billion.
Cordis makes cardiology and endovascular devices. Johnson & Johnson sold the business to Cardinal Health in 2015 for about $2 billion.
The sale of the business to Hellman & Friedman is expected to close in the first half of Cardinal’s fiscal 2022 year, the company said.
“Cordis has a long history of innovation in minimally-invasive cardiovascular technology, and we are confident that with H&F as its owner, Cordis will be well-positioned for growth, innovation and success,” Mike Kaufmann, Cardinal Health’s CEO, said in a news release.
Source: Beckers Hospital Review
By Maia Anderson
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.